Obsidian Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 14.79 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 913.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Details
| Name | Obsidian Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 87 |
| Founded | 2015 |
| Ceo | Madan Jagasia |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US67448A1060 |
| Cusip | 67448A106 |
| Cik | 2130606 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Madan Jagasia M.D., M.S. | President, Chief Executive Officer and Director |
| Dr. Maria Fardis M.B.A., Ph.D. | Executive Chairman of the Board |
| Dana M. Alexander M.B.A. | Chief Technical Officer |
| Dr. Parameswaran Hari M.D., M.S. | Chief Medical Officer |
| Julie B. Feder | Chief Financial Officer |
| Caroline Code | Vice President of Corporate Development and Investor Relations |
| Jennifer H. Peterson | Chief People Officer |
| Dr. Peter Barrett Ph.D. | Secretary and Director |
Contact
| Address | 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States |
| Phone | 781 806 6245 |
| Website | https://obsidiantx.com |